Medicare Enrolled
Dr. Victor Melgen, M.D.
Medical Oncology · Orange City, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Melgen from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Melgen? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Melgen
Dr. Victor Melgen is a medical oncology in Orange City, FL, with 19 years in practice. Based on federal Medicare data, Dr. Melgen performed 148,577 Medicare services across 3,796 unique beneficiaries.
Between the years covered by Open Payments, Dr. Melgen received a total of $14,271 from 83 pharmaceutical and/or device companies across 718 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Melgen is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice▲ Top 17% volume in FL$ $14,271 industry payments
Medicare Practice Summary
Medicare Utilization ↗148,577
Medicare services
Top 17% in FL for medical oncology
3,796
Unique beneficiaries
$4
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~7,820 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) | 63,240 | $0 | $4 |
| Filgrastim injection (Zarxio) for white blood cells | 19,440 | $0 | $2 |
| Iron sucrose injection (Venofer) | 19,300 | $0 | $5 |
| Denosumab injection (Prolia/Xgeva) | 12,960 | $18 | $51 |
| Epoetin alfa injection (Procrit) for anemia | 9,070 | $6 | $23 |
| Anti-nausea injection (aprepitant) | 8,970 | $1 | $5 |
| Dexamethasone injection (steroid) | 2,703 | $0 | $3 |
| Complete blood count (CBC) with differential | 2,403 | $8 | $29 |
| Blood draw (venipuncture) | 2,302 | $8 | $9 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,130 | $1 | $28 |
| Drug injection, under skin or into muscle | 1,017 | $10 | $69 |
| Office visit, established patient (30-39 min) | 916 | $98 | $339 |
| Office visit, established patient (20-29 min) | 798 | $63 | $239 |
| Anti-nausea injection (ondansetron/Zofran) | 704 | $0 | $9 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 497 | $1 | $6 |
| Injection of additional new drug or substance into vein | 397 | $12 | $61 |
| Administration of chemotherapy into vein, 1 hour or less | 394 | $98 | $378 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 277 | $47 | $189 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 253 | $22 | $84 |
| Injection, zoledronic acid, 1 mg | 248 | $6 | $69 |
| Prothrombin time test (blood clotting) | 168 | $4 | $15 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 164 | $16 | $59 |
| Injection, diphenhydramine hcl, up to 50 mg | 128 | $1 | $3 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 127 | $55 | $206 |
| Administration of chemotherapy into vein, each additional hour | 118 | $21 | $79 |
| Administration of additional new drug or substance into vein, 1 hour or less | 106 | $49 | $178 |
| New patient office visit (45-59 min) | 104 | $126 | $453 |
| Injection of drug or substance into vein | 101 | $28 | $156 |
| Injection, magnesium sulfate, per 500 mg | 96 | $1 | $2 |
| Red blood count, automated test | 67 | $4 | $10 |
| Hospital follow-up visit, high complexity | 56 | $94 | $285 |
| Automated urinalysis | 49 | $2 | $8 |
| Drawing of blood for a medical problem | 49 | $68 | $277 |
| Infusion into a vein for hydration, each additional hour | 46 | $10 | $42 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 38 | $14 | $56 |
| Infusion, normal saline solution, sterile (500 ml = 1 unit) | 33 | $1 | $7 |
| Infusion into a vein for hydration, 31-60 minutes | 29 | $24 | $156 |
| Infusion, normal saline solution , 1000 cc | 28 | $2 | $7 |
| Biopsy and aspiration of bone marrow sample for diagnosis | 26 | $133 | $467 |
| Injection, methylprednisolone sodium succinate, up to 40 mg | 25 | $3 | $11 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
43.0% high complexity
52.1% medium
4.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$14,271
Total received (2018-2024)
Avg $2,039/year across 7 years
Top 37% in FL for medical oncology
83
Companies
718
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,629 (95.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$643 (4.5%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$2,897
2023$2,386
2022$1,594
2021$714
2020$1,305
2019$2,005
2018$3,369
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$4,202
Celgene Corporation
$994
Janssen Biotech, Inc.
$838
Genentech USA, Inc.
$624
E.R. Squibb & Sons, L.L.C.
$603
PFIZER INC.
$519
Gilead Sciences, Inc.
$512
Astellas Pharma US Inc
$499
Incyte Corporation
$378
Daiichi Sankyo Inc.
$350
Amgen Inc.
$252
Pharmacyclics LLC, An AbbVie Company
$238
Bayer HealthCare Pharmaceuticals Inc.
$238
GENZYME CORPORATION
$207
Ipsen Biopharmaceuticals, Inc
$203
Merck Sharp & Dohme LLC
$200
Lilly USA, LLC
$158
Foundation Medicine, Inc.
$152
AstraZeneca Pharmaceuticals LP
$148
Merck Sharp & Dohme Corporation
$146
Rigel Pharmaceuticals, Inc.
$145
ABBVIE INC.
$137
Puma Biotechnology, Inc.
$114
Kite Pharma, Inc.
$110
Takeda Pharmaceuticals U.S.A., Inc.
$105
Seagen Inc.
$105
EMD Serono, Inc.
$103
GlaxoSmithKline, LLC.
$98
BeiGene USA, Inc.
$82
TerSera Therapeutics LLC
$82
Alexion Pharmaceuticals, Inc.
$80
ARRAY BIOPHARMA INC
$78
Pharmacyclics LLC, an AbbVie Company
$75
Bayer Healthcare Pharmaceuticals Inc.
$67
Seattle Genetics, Inc.
$63
Eisai Inc.
$61
EISAI INC.
$56
JAZZ PHARMACEUTICALS INC.
$54
Stemline Therapeutics Inc.
$54
Aurobindo Pharma USA, Inc.
$49
Mirati Therapeutics, Inc.
$44
Exelixis Inc.
$43
Adaptive Biotechnologies Corporation
$42
MEDIVATION FIELD SOLUTIONS LLC
$41
CSL Behring
$41
TAIHO ONCOLOGY, INC.
$40
G1 Therapeutics, Inc.
$38
Lexicon Pharmaceuticals, Inc.
$36
MorphoSys, US Inc.
$35
ADC Therapeutics America, Inc.
$34
AMAG Pharmaceuticals, Inc.
$34
Partner Therapeutics, Inc.
$33
Karyopharm Therapeutics Inc.
$31
Coherus Biosciences Inc.
$30
Spectrum Pharmaceuticals Inc.
$30
Global Blood Therapeutics, Inc.
$28
Fortovia Therapeutics, Inc.
$27
AVEO Pharmaceuticals, Inc.
$27
Dendreon Pharmaceuticals LLC
$25
Apellis Pharmaceuticals, Inc.
$24
Tolmar, Inc.
$24
RECORDATI_RARE_DISEASES_INC.
$23
Sun Pharmaceutical Industries Inc.
$23
Agios Pharmaceuticals, Inc.
$23
EUSA Pharma (US) LLC
$23
Acrotech Biopharma Inc.
$22
SpringWorks Therapeutics, Inc.
$22
SOBI, INC
$20
CTI BioPharma Corp.
$20
AbbVie, Inc.
$19
SERVIER PHARMACEUTICALS LLC
$18
Boehringer Ingelheim Pharmaceuticals, Inc.
$18
Regeneron Healthcare Solutions, Inc.
$17
Janssen Pharmaceuticals, Inc
$16
West Therapeutics Development, LLC
$16
Servier Pharmaceuticals LLC
$16
Sirtex Medical Inc
$15
Blueprint Medicines Corporation
$15
Sobi, Inc
$14
Sysmex Inostics Inc
$14
Dova Pharmaceuticals
$14
NanoString Technologies, Inc.
$12
Veracyte, Inc.
$1
Top 3 companies account for 42.3% of total payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · AYVAKIT · Afstyla · Alecensa · Aliqopa · Avastin · BELEODAQ · BENLYSTA · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · CABLIVI · CERDELGA · CEREZYME · COSELA · CYRAMZA · Cabometyx · DARZALEX · DOPTELET · Doptelet · ELIGARD · ELIQUIS · ELREXFIO · EMEND · EMPLICITI · ENHERTU · EPKINLY · ERLEADA · Empaveli · Enhertu · Erleada · FERAHEME · FOTIVDA · FOUNDATIONONE · FOUNDATIONONE CDX · FRUZAQLA · Fabhalta · Folotyn · GAZYVA · GILOTRIF · Gazyva · IBRANCE · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INREBIC · Idelvion · Imbruvica · JAKAFI · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · Kyprolis · LENVIMA · LEUKINE · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lazanda · Lenvima · Leukine · MEKINIST · MONJUVI · NINLARO · Nerlynx · Neulasta · Nplate · Nubeqa · ODOMZO · OGSIVEO · ONUREG · OPDIVO · OPDUALAG · OXBRYTA · Onivyde · Orserdu · PADCEV · PIQRAY · PROMACTA · PROSIGNA ASSAY · PROVENGE · PYRUKYND · Padcev · Perjeta · Phesgo · Polivy · Pomalyst · Quzyttir · REBLOZYL · RETEVMO · ROLVEDON · RYBREVANT · Revlimid · Rezlidhia · SANDOSTATIN · SANDOSTATIN LAR · SARCLISA · SCEMBLIX · SIR-Spheres Microspheres · SOLIRIS · SOMATULINE DEPOT · SUTENT · SYLVANT · Somatuline Depot · Stivarga · Sylvant · TASIGNA · TECENTRIQ · TECVAYLI · TIBSOVO · TUKYSA · Tavalisse · Tecentriq · Tibsovo · Trodelvy · Udenyca · VENCLEXTA · VERZENIO · VOTRIENT · Vanflyta · Venclexta · Vitrakvi · Vonjo · Vyloy · XALKORI · XARELTO · XOSPATA · XPOVIO · XTANDI · Xermelo · Xofigo · Xospata · Xtandi · Yescarta · ZEJULA · ZEPZELCA · ZOLADEX · Zevalin · Zoladex · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (96%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $10 per 100 Medicare services performed
Geographic Context
Medical Oncologys within 10 mi
13
Per 100K population
2.3
County median income
$66,581
Nearest hospital
ADVENTHEALTH FISH MEMORIAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Melgen is a mixed practice specialist, with above-average Medicare volume (top 17% in FL), and low-engagement industry engagement, with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Melgen experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Melgen performed 63,240 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Melgen receive payments from pharmaceutical companies?
Yes. Dr. Melgen received a total of $14,271 from 83 companies across 718 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Melgen's costs compare to other medical oncologys in Orange City?
Dr. Melgen's average Medicare payment per service is $4. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Melgen) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Medical Oncologys in Orange City
Browse medical oncologys in Orange City ranked by procedure volume and transparency data.
Highest volume
Top Medical Oncologys in FL
Medical Oncologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Medical Oncologys in FL
Which FL medical oncologys receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Celgene Corporation Payments to Doctors
See all physicians who received payments from Celgene Corporation.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology